Literature DB >> 23541550

Impact of hospital volume and type on outcomes of open and endovascular repair of descending thoracic aneurysms in the United States Medicare population.

Virendra I Patel1, Shankha Mukhopadhyay, Emel Ergul, Nathan Aranson, Mark F Conrad, Glenn M Lamuraglia, Christopher J Kwolek, Richard P Cambria.   

Abstract

OBJECTIVE: Favorable outcomes of thoracic endovascular aortic repair (TEVAR) compared with open repair for descending thoracic aortic aneurysms (DTAs) have led to increasing TEVAR use. We evaluated the effect of case volume and hospital teaching status on clinical outcomes of intact DTA repair.
METHODS: The Medicare Provider Analysis and Review (MEDPAR) data set (2004 to 2007) was queried to identify open repair or TEVAR for DTA. Hospitals were stratified by DTA volume into high volume (HV; ≥ 8 cases/y) or low volume (LV; <8 cases/y) and teaching or nonteaching. The effect of hospital variables on the primary study end point of 30-day mortality and secondary end points of 30-day complications and long-term survival after open repair and TEVAR DTA repair were studied using univariate testing, multivariable regression modeling, Kaplan-Meier survival analysis, and Cox proportional hazards regression modeling.
RESULTS: We identified 763 hospitals performing 3554 open repairs and 3517 TEVARs. Overall DTA repair increased (P < .01) from 1375 in 2004 to 1987 in 2007. The proportion of hospitals performing open repair significantly decreased from 95% in 2004 to 57% in 2007 (P < .01), whereas those performing TEVAR increased (P < .01) from 24% to 76%. Overall repair type shifted from open (74% in 2004, the year before initial commercial availability of TEVAR) to TEVAR (39% open in 2007; P < .01). The fraction of open repairs at LV hospitals decreased from 56% in 2004 to 44% in 2007 (P < .01), whereas TEVAR increased from 24% in 2004 to 51% in 2007 (P < .01). Overall mortality during the study interval for open repair was 15% at LV hospitals vs 11% at HV hospitals (P < .01), whereas TEVAR mortality was similar, at 3.9% in LV vs 5.5% in HV hospitals (P = .43). LV was independently associated with increased mortality after open repair (odds ratio, 1.4; 95% confidence interval, 1.1-1.8; P < .01) but not after TEVAR. There was no independent effect of hospital teaching status on mortality or complications after open repair or TEVAR repair.
CONCLUSIONS: The total number of DTA repairs has significantly increased. Operative mortality for TEVAR is independent of hospital volume and type, whereas mortality after open surgery is lower at HV hospitals, suggesting that TEVAR can be safely performed across a spectrum of hospitals, whereas open surgery should be performed only at HV hospitals.
Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541550     DOI: 10.1016/j.jvs.2013.01.035

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  9 in total

1.  The price of decreased mortality in the operative management of diverticulitis.

Authors:  Ryan C Broderick; Hans F Fuchs; Cristina R Harnsberger; David C Chang; Elisabeth McLemore; Sonia Ramamoorthy; Santiago Horgan
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

2.  Increasing the Value of Healthcare: Improving Mortality While Reducing Cost in Bariatric Surgery.

Authors:  Ryan C Broderick; Hans F Fuchs; Cristina R Harnsberger; David C Chang; Bryan J Sandler; Garth R Jacobsen; Santiago Horgan
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

Review 3.  Debranching aortic surgery.

Authors:  Manuel Alonso Pérez; José Manuel Llaneza Coto; José Antonio Del Castro Madrazo; Carlota Fernández Prendes; Mario González Gay; Amer Zanabili Al-Sibbai
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

4.  Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.

Authors:  Emily Z Keung; Yi-Ju Chiang; Janice N Cormier; Keila E Torres; Kelly K Hunt; Barry W Feig; Christina L Roland
Journal:  Cancer       Date:  2018-10-14       Impact factor: 6.860

5.  Volume-Outcome Relationships in Surgical and Endovascular Repair of Aortic Dissection.

Authors:  Alexander A Brescia; Himanshu J Patel; Donald S Likosky; Tessa M F Watt; Xiaoting Wu; Raymond J Strobel; Karen M Kim; Shinichi Fukuhara; Bo Yang; G Michael Deeb; Michael P Thompson
Journal:  Ann Thorac Surg       Date:  2019-08-07       Impact factor: 4.330

6.  Characterizing endovascular aortic intervention outcomes for nonruptured aortic aneurysms by physician specialty.

Authors:  Andres Guerra; Joe M Feinglass; Matthew C Chia; Ashley K Vavra
Journal:  Surgery       Date:  2022-01-26       Impact factor: 3.982

7.  Hybrid treatment of aortic arch disease.

Authors:  Patrick Bastos Metzger; Fabio Henrique Rossi; Samuel Martins Moreira; Mario Issa; Nilo Mitsuru Izukawa; Jarbas J Dinkhuysen; Domingos Spina Neto; Antônio Massamitsu Kambara
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

Review 8.  Unwarranted Variation in the Quality of Care for Patients With Diseases of the Thoracic Aorta.

Authors:  Alex Bottle; Giovanni Mariscalco; Matthew A Shaw; Umberto Benedetto; Athanasios Saratzis; Silvia Mariani; Mohamad Bashir; Paul Aylin; David Jenkins; Aung Y Oo; Gavin J Murphy
Journal:  J Am Heart Assoc       Date:  2017-03-14       Impact factor: 5.501

9.  Off pump hybrid extra-anatomic techniques for aortic arch repair-own experience.

Authors:  Piotr Buczkowski; Mateusz Puslecki; Sebastian Stefaniak; Robert Juszkat; Jerzy Kulesza; Marcin Misterski; Tomasz Urbanowicz; Marcin Ligowski; Bartosz Zabicki; Marek Dabrowski; Lukasz Szarpak; Damian Gorczyca; Marek Jemielity; Bartłomiej Perek
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.